Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy
This pilot study analyses weight gain in type 2 diabetic patients at initiation of insulin therapy, according to daily calcium intake. Type 2 diabetic patients consecutively admitted for initiation of insulin therapy were studied between January and March 2004 in a monocenter study. Dietary intake w...
Gespeichert in:
| Veröffentlicht in: | Diabetes & metabolism 2006-09, Vol.32 (4), p.358-363 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 363 |
|---|---|
| container_issue | 4 |
| container_start_page | 358 |
| container_title | Diabetes & metabolism |
| container_volume | 32 |
| creator | Duengler, F Torremocha, F Yameogo, M Marechaud, R Hadjadj, S |
| description | This pilot study analyses weight gain in type 2 diabetic patients at initiation of insulin therapy, according to daily calcium intake.
Type 2 diabetic patients consecutively admitted for initiation of insulin therapy were studied between January and March 2004 in a monocenter study. Dietary intake was assessed by a 7-day food history before insulin treatment (initial visit) and 4 to 6 months later (final visit).
Thirty-one patients were studied (18 males and 13 females; mean age 62±9 years, with diabetes duration 14±10 years). Weight significantly increased between initial and final visits (81.9±16.2 vs. 84.8±17.8 kg; P=0.0272). Median weight gain was 2.4 kg (IQR: -1.15 to +5.27 kg). Waist circumference increased by 2 cm (IQR: 0 to +4 cm). There was no difference between weight change and tertile of calcium intake adjusted on energy intake. We did not find any correlation between weight change and total calcium intake (Rho=0.186; P=0.3165) or dairy calcium intake (Rho=0191; P=0.3040). Similarly, we did not find any correlation between waist circumference change and total calcium intake (Rho=0.324; P=0.1205) or dairy calcium intake (Rho=0.285; P=0.0755).
We found no relation between total or dairy calcium intake and weight change during initiation of insulin therapy in type 2 diabetic patients. Dietary calcium intake does probably not play a major role on insulin-induced body weight gain.
Influence des apports alimentaires en calcium sur la prise de poids observée chez les diabétiques de type 2 après mise à l'insuline
Cette étude pilote analyse la prise pondérale à la mise en route d'un traitement insulinique chez des sujets diabétiques de type 2, en fonction de l'apport calcique.
Des patients diabétiques de type 2 admis pour mise à l'insuline entre janvier et mars 2004 ont été étudiés dans une étude mono-centrique. Les apports alimentaires étaient estimés par l'interrogatoire alimentaire sur 7 jours, avant le début (visite initiale) et 4 à 6 mois plus tard (visite finale).
31 sujets ont été étudiés (18 hommes et 13 femmes; age moyen : 62 ± 9 ans et durée connue de diabète 14 ± 10 ans). Le poids a augmenté significativement entre la visite initiale et la visite finale : 81,9 ± 16.2 vs 84,8 ± 17,8 Kg; P = 0,0272). La prise de poids médiane était de 2,4 Kg (IQR : -1,15 à 5,27). La médiane de tour de taille a augmenté de 2 cm (IQR : 0 à 4). Il n'y avait pas de différence de prise de poids en fonction du tertile d'apport calcique/ apport énergétique. Nous n'avo |
| doi_str_mv | 10.1016/S1262-3636(07)70291-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68854811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1262363607702914</els_id><sourcerecordid>68854811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-193cbff4330d96a25dce4d4e6cbca01313068f55ee20e1169def1adfb55711413</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EoqXwCCBfQHBI8cSxk5wQqgpFqtQDcLYce7wdyCbBdqj27fF2F_XYk63R98-MPzP2GsQ5CNAfv0Ot60pqqd-L9kMr6h6q5gk7ha7tKmg78bTc_yMn7EVKv4SAupfdc3YCum_bWjenLF2GgC7zOXBPmG3ccWdHR-uW05Ttb-TzxO-QNreZbyxNpcrzbkFeF94OmMnxxWbCKSce5nGc72jaFIoylXIJl840pXXcB28x2mX3kj0Ldkz46niesZ9fLn9cXFXXN1-_XXy-rpzsZa6gl24IoZFS-F7bWnmHjW9Qu8FZARKk0F1QCrEWCOVJHgNYHwalWoAG5Bl7d-i7xPnPiimbLSWH42gnnNdkdNeppoM9qA6gi3NKEYNZIm2LCwPC7G2be9tmr9KI1tzbNk3JvTkOWIct-ofUUW8B3h4Bm4rWEO3kKD1wZXivVF-4TwcOi46_hNEkV5Q69BTL7xg_0yOr_APehp2L</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68854811</pqid></control><display><type>article</type><title>Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Duengler, F ; Torremocha, F ; Yameogo, M ; Marechaud, R ; Hadjadj, S</creator><creatorcontrib>Duengler, F ; Torremocha, F ; Yameogo, M ; Marechaud, R ; Hadjadj, S</creatorcontrib><description>This pilot study analyses weight gain in type 2 diabetic patients at initiation of insulin therapy, according to daily calcium intake.
Type 2 diabetic patients consecutively admitted for initiation of insulin therapy were studied between January and March 2004 in a monocenter study. Dietary intake was assessed by a 7-day food history before insulin treatment (initial visit) and 4 to 6 months later (final visit).
Thirty-one patients were studied (18 males and 13 females; mean age 62±9 years, with diabetes duration 14±10 years). Weight significantly increased between initial and final visits (81.9±16.2 vs. 84.8±17.8 kg; P=0.0272). Median weight gain was 2.4 kg (IQR: -1.15 to +5.27 kg). Waist circumference increased by 2 cm (IQR: 0 to +4 cm). There was no difference between weight change and tertile of calcium intake adjusted on energy intake. We did not find any correlation between weight change and total calcium intake (Rho=0.186; P=0.3165) or dairy calcium intake (Rho=0191; P=0.3040). Similarly, we did not find any correlation between waist circumference change and total calcium intake (Rho=0.324; P=0.1205) or dairy calcium intake (Rho=0.285; P=0.0755).
We found no relation between total or dairy calcium intake and weight change during initiation of insulin therapy in type 2 diabetic patients. Dietary calcium intake does probably not play a major role on insulin-induced body weight gain.
Influence des apports alimentaires en calcium sur la prise de poids observée chez les diabétiques de type 2 après mise à l'insuline
Cette étude pilote analyse la prise pondérale à la mise en route d'un traitement insulinique chez des sujets diabétiques de type 2, en fonction de l'apport calcique.
Des patients diabétiques de type 2 admis pour mise à l'insuline entre janvier et mars 2004 ont été étudiés dans une étude mono-centrique. Les apports alimentaires étaient estimés par l'interrogatoire alimentaire sur 7 jours, avant le début (visite initiale) et 4 à 6 mois plus tard (visite finale).
31 sujets ont été étudiés (18 hommes et 13 femmes; age moyen : 62 ± 9 ans et durée connue de diabète 14 ± 10 ans). Le poids a augmenté significativement entre la visite initiale et la visite finale : 81,9 ± 16.2 vs 84,8 ± 17,8 Kg; P = 0,0272). La prise de poids médiane était de 2,4 Kg (IQR : -1,15 à 5,27). La médiane de tour de taille a augmenté de 2 cm (IQR : 0 à 4). Il n'y avait pas de différence de prise de poids en fonction du tertile d'apport calcique/ apport énergétique. Nous n'avons pas noté de relation entre la prise de poids et l'apport calcique total (Rho = 0,186; P = 0,3165), ni l'apport en calcium laitier (Rho = 0,191; P = 0,3040). De même, nous n'avons pas noté de relation entre la modification du tour de taille et l'apport calcique total (Rho = 0,324; P = 0,1205), ni l'apport en calcium laitier (Rho = 0,285; P = 0,0755).
Nous n'avons trouvé aucune relation entre l'apport calcique total ou en calcium laitier et les modifications de poids à la mise en route d'une insulinothérapie chez des patients diabétiques de type 2. L'apport calcique ne joue probablement pas de rôle majeur dans la prise de poids induite par l'insuline.</description><identifier>ISSN: 1262-3636</identifier><identifier>EISSN: 1878-1780</identifier><identifier>DOI: 10.1016/S1262-3636(07)70291-4</identifier><identifier>PMID: 16977264</identifier><language>eng</language><publisher>Paris: Elsevier Masson SAS</publisher><subject>Aged ; Apport calcique ; Biological and medical sciences ; Calcium intake ; Calcium laitier ; Calcium, Dietary ; Dairy products ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetes. Impaired glucose tolerance ; Diabète de type 2 ; Diet Records ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Energy Intake ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Humans ; Hypoglycemic Agents - therapeutic use ; Insulin - therapeutic use ; Insulin therapy ; Insulinothérapie ; Male ; Medical sciences ; Middle Aged ; Poids ; Type 2 diabetes ; Weight ; Weight Gain</subject><ispartof>Diabetes & metabolism, 2006-09, Vol.32 (4), p.358-363</ispartof><rights>2006 Elsevier Masson SAS</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-193cbff4330d96a25dce4d4e6cbca01313068f55ee20e1169def1adfb55711413</citedby><cites>FETCH-LOGICAL-c393t-193cbff4330d96a25dce4d4e6cbca01313068f55ee20e1169def1adfb55711413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S1262-3636(07)70291-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18119559$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16977264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duengler, F</creatorcontrib><creatorcontrib>Torremocha, F</creatorcontrib><creatorcontrib>Yameogo, M</creatorcontrib><creatorcontrib>Marechaud, R</creatorcontrib><creatorcontrib>Hadjadj, S</creatorcontrib><title>Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy</title><title>Diabetes & metabolism</title><addtitle>Diabetes Metab</addtitle><description>This pilot study analyses weight gain in type 2 diabetic patients at initiation of insulin therapy, according to daily calcium intake.
Type 2 diabetic patients consecutively admitted for initiation of insulin therapy were studied between January and March 2004 in a monocenter study. Dietary intake was assessed by a 7-day food history before insulin treatment (initial visit) and 4 to 6 months later (final visit).
Thirty-one patients were studied (18 males and 13 females; mean age 62±9 years, with diabetes duration 14±10 years). Weight significantly increased between initial and final visits (81.9±16.2 vs. 84.8±17.8 kg; P=0.0272). Median weight gain was 2.4 kg (IQR: -1.15 to +5.27 kg). Waist circumference increased by 2 cm (IQR: 0 to +4 cm). There was no difference between weight change and tertile of calcium intake adjusted on energy intake. We did not find any correlation between weight change and total calcium intake (Rho=0.186; P=0.3165) or dairy calcium intake (Rho=0191; P=0.3040). Similarly, we did not find any correlation between waist circumference change and total calcium intake (Rho=0.324; P=0.1205) or dairy calcium intake (Rho=0.285; P=0.0755).
We found no relation between total or dairy calcium intake and weight change during initiation of insulin therapy in type 2 diabetic patients. Dietary calcium intake does probably not play a major role on insulin-induced body weight gain.
Influence des apports alimentaires en calcium sur la prise de poids observée chez les diabétiques de type 2 après mise à l'insuline
Cette étude pilote analyse la prise pondérale à la mise en route d'un traitement insulinique chez des sujets diabétiques de type 2, en fonction de l'apport calcique.
Des patients diabétiques de type 2 admis pour mise à l'insuline entre janvier et mars 2004 ont été étudiés dans une étude mono-centrique. Les apports alimentaires étaient estimés par l'interrogatoire alimentaire sur 7 jours, avant le début (visite initiale) et 4 à 6 mois plus tard (visite finale).
31 sujets ont été étudiés (18 hommes et 13 femmes; age moyen : 62 ± 9 ans et durée connue de diabète 14 ± 10 ans). Le poids a augmenté significativement entre la visite initiale et la visite finale : 81,9 ± 16.2 vs 84,8 ± 17,8 Kg; P = 0,0272). La prise de poids médiane était de 2,4 Kg (IQR : -1,15 à 5,27). La médiane de tour de taille a augmenté de 2 cm (IQR : 0 à 4). Il n'y avait pas de différence de prise de poids en fonction du tertile d'apport calcique/ apport énergétique. Nous n'avons pas noté de relation entre la prise de poids et l'apport calcique total (Rho = 0,186; P = 0,3165), ni l'apport en calcium laitier (Rho = 0,191; P = 0,3040). De même, nous n'avons pas noté de relation entre la modification du tour de taille et l'apport calcique total (Rho = 0,324; P = 0,1205), ni l'apport en calcium laitier (Rho = 0,285; P = 0,0755).
Nous n'avons trouvé aucune relation entre l'apport calcique total ou en calcium laitier et les modifications de poids à la mise en route d'une insulinothérapie chez des patients diabétiques de type 2. L'apport calcique ne joue probablement pas de rôle majeur dans la prise de poids induite par l'insuline.</description><subject>Aged</subject><subject>Apport calcique</subject><subject>Biological and medical sciences</subject><subject>Calcium intake</subject><subject>Calcium laitier</subject><subject>Calcium, Dietary</subject><subject>Dairy products</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabète de type 2</subject><subject>Diet Records</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Energy Intake</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin - therapeutic use</subject><subject>Insulin therapy</subject><subject>Insulinothérapie</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Poids</subject><subject>Type 2 diabetes</subject><subject>Weight</subject><subject>Weight Gain</subject><issn>1262-3636</issn><issn>1878-1780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EoqXwCCBfQHBI8cSxk5wQqgpFqtQDcLYce7wdyCbBdqj27fF2F_XYk63R98-MPzP2GsQ5CNAfv0Ot60pqqd-L9kMr6h6q5gk7ha7tKmg78bTc_yMn7EVKv4SAupfdc3YCum_bWjenLF2GgC7zOXBPmG3ccWdHR-uW05Ttb-TzxO-QNreZbyxNpcrzbkFeF94OmMnxxWbCKSce5nGc72jaFIoylXIJl840pXXcB28x2mX3kj0Ldkz46niesZ9fLn9cXFXXN1-_XXy-rpzsZa6gl24IoZFS-F7bWnmHjW9Qu8FZARKk0F1QCrEWCOVJHgNYHwalWoAG5Bl7d-i7xPnPiimbLSWH42gnnNdkdNeppoM9qA6gi3NKEYNZIm2LCwPC7G2be9tmr9KI1tzbNk3JvTkOWIct-ofUUW8B3h4Bm4rWEO3kKD1wZXivVF-4TwcOi46_hNEkV5Q69BTL7xg_0yOr_APehp2L</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Duengler, F</creator><creator>Torremocha, F</creator><creator>Yameogo, M</creator><creator>Marechaud, R</creator><creator>Hadjadj, S</creator><general>Elsevier Masson SAS</general><general>Masson</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy</title><author>Duengler, F ; Torremocha, F ; Yameogo, M ; Marechaud, R ; Hadjadj, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-193cbff4330d96a25dce4d4e6cbca01313068f55ee20e1169def1adfb55711413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Apport calcique</topic><topic>Biological and medical sciences</topic><topic>Calcium intake</topic><topic>Calcium laitier</topic><topic>Calcium, Dietary</topic><topic>Dairy products</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabète de type 2</topic><topic>Diet Records</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Energy Intake</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin - therapeutic use</topic><topic>Insulin therapy</topic><topic>Insulinothérapie</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Poids</topic><topic>Type 2 diabetes</topic><topic>Weight</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duengler, F</creatorcontrib><creatorcontrib>Torremocha, F</creatorcontrib><creatorcontrib>Yameogo, M</creatorcontrib><creatorcontrib>Marechaud, R</creatorcontrib><creatorcontrib>Hadjadj, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duengler, F</au><au>Torremocha, F</au><au>Yameogo, M</au><au>Marechaud, R</au><au>Hadjadj, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy</atitle><jtitle>Diabetes & metabolism</jtitle><addtitle>Diabetes Metab</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>32</volume><issue>4</issue><spage>358</spage><epage>363</epage><pages>358-363</pages><issn>1262-3636</issn><eissn>1878-1780</eissn><abstract>This pilot study analyses weight gain in type 2 diabetic patients at initiation of insulin therapy, according to daily calcium intake.
Type 2 diabetic patients consecutively admitted for initiation of insulin therapy were studied between January and March 2004 in a monocenter study. Dietary intake was assessed by a 7-day food history before insulin treatment (initial visit) and 4 to 6 months later (final visit).
Thirty-one patients were studied (18 males and 13 females; mean age 62±9 years, with diabetes duration 14±10 years). Weight significantly increased between initial and final visits (81.9±16.2 vs. 84.8±17.8 kg; P=0.0272). Median weight gain was 2.4 kg (IQR: -1.15 to +5.27 kg). Waist circumference increased by 2 cm (IQR: 0 to +4 cm). There was no difference between weight change and tertile of calcium intake adjusted on energy intake. We did not find any correlation between weight change and total calcium intake (Rho=0.186; P=0.3165) or dairy calcium intake (Rho=0191; P=0.3040). Similarly, we did not find any correlation between waist circumference change and total calcium intake (Rho=0.324; P=0.1205) or dairy calcium intake (Rho=0.285; P=0.0755).
We found no relation between total or dairy calcium intake and weight change during initiation of insulin therapy in type 2 diabetic patients. Dietary calcium intake does probably not play a major role on insulin-induced body weight gain.
Influence des apports alimentaires en calcium sur la prise de poids observée chez les diabétiques de type 2 après mise à l'insuline
Cette étude pilote analyse la prise pondérale à la mise en route d'un traitement insulinique chez des sujets diabétiques de type 2, en fonction de l'apport calcique.
Des patients diabétiques de type 2 admis pour mise à l'insuline entre janvier et mars 2004 ont été étudiés dans une étude mono-centrique. Les apports alimentaires étaient estimés par l'interrogatoire alimentaire sur 7 jours, avant le début (visite initiale) et 4 à 6 mois plus tard (visite finale).
31 sujets ont été étudiés (18 hommes et 13 femmes; age moyen : 62 ± 9 ans et durée connue de diabète 14 ± 10 ans). Le poids a augmenté significativement entre la visite initiale et la visite finale : 81,9 ± 16.2 vs 84,8 ± 17,8 Kg; P = 0,0272). La prise de poids médiane était de 2,4 Kg (IQR : -1,15 à 5,27). La médiane de tour de taille a augmenté de 2 cm (IQR : 0 à 4). Il n'y avait pas de différence de prise de poids en fonction du tertile d'apport calcique/ apport énergétique. Nous n'avons pas noté de relation entre la prise de poids et l'apport calcique total (Rho = 0,186; P = 0,3165), ni l'apport en calcium laitier (Rho = 0,191; P = 0,3040). De même, nous n'avons pas noté de relation entre la modification du tour de taille et l'apport calcique total (Rho = 0,324; P = 0,1205), ni l'apport en calcium laitier (Rho = 0,285; P = 0,0755).
Nous n'avons trouvé aucune relation entre l'apport calcique total ou en calcium laitier et les modifications de poids à la mise en route d'une insulinothérapie chez des patients diabétiques de type 2. L'apport calcique ne joue probablement pas de rôle majeur dans la prise de poids induite par l'insuline.</abstract><cop>Paris</cop><pub>Elsevier Masson SAS</pub><pmid>16977264</pmid><doi>10.1016/S1262-3636(07)70291-4</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1262-3636 |
| ispartof | Diabetes & metabolism, 2006-09, Vol.32 (4), p.358-363 |
| issn | 1262-3636 1878-1780 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68854811 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Aged Apport calcique Biological and medical sciences Calcium intake Calcium laitier Calcium, Dietary Dairy products Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Diabetes. Impaired glucose tolerance Diabète de type 2 Diet Records Endocrine pancreas. Apud cells (diseases) Endocrinopathies Energy Intake Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Insulin therapy Insulinothérapie Male Medical sciences Middle Aged Poids Type 2 diabetes Weight Weight Gain |
| title | Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A14%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20dietary%20calcium%20intake%20on%20weight%20gain%20in%20type%202%20diabetic%20patients%20following%20initiation%20of%20insulin%20therapy&rft.jtitle=Diabetes%20&%20metabolism&rft.au=Duengler,%20F&rft.date=2006-09-01&rft.volume=32&rft.issue=4&rft.spage=358&rft.epage=363&rft.pages=358-363&rft.issn=1262-3636&rft.eissn=1878-1780&rft_id=info:doi/10.1016/S1262-3636(07)70291-4&rft_dat=%3Cproquest_cross%3E68854811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68854811&rft_id=info:pmid/16977264&rft_els_id=S1262363607702914&rfr_iscdi=true |